ArticleAmerican journal of ophthalmology case reports2026
Concurrent Von Hippel-Lindau disease and enhanced S-cone syndrome leading to a distinct retinal phenotype.
Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Von Hippel-Lindau (VHL) disease and Enhanced S-cone syndrome (ESCS) are rare inherited disorders that independently predispose to vision-threatening retinal pathology through distinct mechanisms: VHL through hypoxia-induced activation of several angiogenic factors, which lead to the development of retinal capillary hemangioblastoma (RCH), and ESCS by disrupting photoreceptor development through Methods: A retrospective case report. Results: A 13-year-old girl presented with poor vision in both eyes, mainly in dim light. Fundus examination revealed multiple small hypopigmented areas distributed nasally and temporally along the inferior arcades in both eyes, and multiple small RCHs distributed in all quadrants with superonasal exudations and macular choroidal neovascular membrane (CNVM) in the left eye. Full-field electroretinography (ff-ERG) showed nonrecordable rod responses, broadened rod-cone and cone responses, and a markedly reduced 30-Hz flicker amplitude. While the right eye was successfully managed conservatively, targeted focal laser and intravitreal anti-vascular endothelial growth factor (VEGF) therapy led to regression of neovascular lesions and visual improvement in the left eye. Whole-exome sequencing identified a heterozygous Conclusion: Both VHL disease and ESCS manifested their characteristic retinal findings of RCH, along with the typical electrophysiological features and the CNVM associated with ESCS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.